Detalles de la búsqueda
1.
Testing and Treatment Interventions in Community Settings Key to Controlling a Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Glasgow: A Modeling Study.
J Infect Dis
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38775628
2.
Impact of the COVID-19 Pandemic on HIV Test Uptake Among People Who Inject Drugs in the Context of an HIV Outbreak.
AIDS Behav
; 28(6): 2131-2147, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649554
3.
Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity.
Hepatology
; 75(2): 369-378, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34453350
4.
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Liver Int
; 43(4): 917-927, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708150
5.
Securing wider EU commitment to the elimination of hepatitis C virus.
Liver Int
; 43(2): 276-291, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196744
6.
Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study.
Epidemiol Infect
; 151: e59, 2023 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915219
7.
Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts.
BMC Public Health
; 23(1): 54, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36611156
8.
Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs.
J Hepatol
; 76(3): 549-557, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34634387
9.
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
Am J Gastroenterol
; 117(9): 1454-1461, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973177
10.
Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study.
Liver Int
; 42(3): 561-574, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951109
11.
Supporting safe and gradual reduction of long-term benzodiazepine receptor agonist use: Development of the SAFEGUARDING-BZRAs toolkit using a codesign approach.
Health Expect
; 25(4): 1904-1918, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672924
12.
A global investment framework for the elimination of hepatitis B.
J Hepatol
; 74(3): 535-549, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32971137
13.
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.
Gastroenterology
; 159(4): 1276-1289.e7, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32561361
14.
Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study.
BMC Med
; 19(1): 149, 2021 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158021
15.
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study.
BMC Med
; 19(1): 51, 2021 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33612113
16.
The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018.
J Viral Hepat
; 28(10): 1452-1463, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34270172
17.
Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortality.
J Viral Hepat
; 28(9): 1246-1255, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002914
18.
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study.
Gut
; 69(12): 2223-2231, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32217640
19.
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
PLoS Med
; 17(10): e1003374, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079969
20.
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
J Hepatol
; 73(6): 1368-1378, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32707225